Dimensional Fund Advisors
FTH

Dimensional Fund Advisors’s Faeth Therapeutics FTH Stock Holding History

Dimensional Fund Advisors’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-579
Closed -$13.2K – 3502
2023
Q2 		$13.2K Hold
579
– – ﹤0.01% 3462
2023
Q1 		$17.4K Hold
579
– – ﹤0.01% 3441
2022
Q4 		$17 Hold
579
– – ﹤0.01% 3468
2022
Q3 		$18K Buy
+579
New +$22.8K ﹤0.01% 3465

Other funds holding FTH

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors's FTH Position: Q3 2023 in Review

Dimensional Fund Advisors sold out of Faeth Therapeutics (FTH) in Q3 2023, closing a stake of 579 shares — an estimated $13.2K sold.

Dimensional Fund Advisors first reported a position in FTH in Q3 2022 and held it in 4 quarters. The position peaked at $18K in Q3 2022. 21 funds tracked by Wall St. Rank hold FTH as of Q3 2023.

  • Dimensional Fund Advisors reported no remaining Faeth Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 579 Faeth Therapeutics shares in Q3 2023, an estimated $13.2K.
  • Dimensional Fund Advisors first reported a position in Faeth Therapeutics in Q3 2022 and held it in 4 quarters.
  • Dimensional Fund Advisors's Faeth Therapeutics position peaked at $18K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2023.

Based on Dimensional Fund Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.